KIT and yolk sac tumor: Furthermore, 80.0% (12 out of15) patients were tested positive for CD117, and in the case of Ki-67 (%), which ranged between 25% and 90%, a positive correlation was observed with the content of yolk sac tumor component, showing its potential as an important immunohistochemical indicator.